Dermapharm Holding SE — Director's Dealing 2023

Jan 11, 2023

News Details

Directors’ Dealings | 11 January 2023 11:06

Dermapharm Holding SE: Christof Dreibholz, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

11.01.2023 / 11:06 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name:	Christof
Last name(s):	Dreibholz

2. Reason for the notification

a) Position / status

Position:	Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Dermapharm Holding SE

b) LEI

5299009F0KNZINQQQK37

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A2GS5D8

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s)	Volume(s)
38.1000 EUR	7,620.00 EUR
38.1000 EUR	7,620.00 EUR
38.2200 EUR	34,398.00 EUR

d) Aggregated information

Price	Aggregated volume
38.1831 EUR	49,638.0000 EUR

e) Date of the transaction

2023-01-10; UTC+1

f) Place of the transaction

Name:	Tradegate Exchange
MIC:	TGAT

---

11.01.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	Dermapharm Holding SE
	Lil-Dagover-Ring 7
	82031 Grünwald
	Germany
Internet:	ir.dermapharm.de

End of News	EQS News Service